← Back to Search

Diagnostic Device

CloudCath Monitoring for Peritoneal Dialysis Infections (ACT Trial)

N/A
Recruiting
Research Sponsored by CloudCath
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently using peritoneal dialysis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights

ACT Trial Summary

This trial will test if the CloudCath device, which uses a small sensor to monitor patients' dialysis fluid for changes that may indicate an infection, can detect these infections as fast or faster than the current standard methods.

Who is the study for?
This trial is for individuals currently using in-home peritoneal dialysis, who can give informed consent and will follow the study's requirements. They must have cellular data at home. People with recent cancer treatments, peritonitis, current infections, or involvement in other studies that could affect results are excluded.Check my eligibility
What is being tested?
The CloudCath System is being tested to see if it can detect infections from peritoneal dialysis quicker or as quickly as existing methods. The goal is to improve early infection detection which is crucial for patients undergoing this treatment.See study design
What are the potential side effects?
Since the CloudCath System is a diagnostic device rather than a medication, traditional side effects like those seen with drugs are not expected. However, there may be risks associated with incorrect readings leading to delayed infection management.

ACT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently on peritoneal dialysis.

ACT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to peritonitis diagnosis
Secondary outcome measures
Agreement in detection of clinically actionable events between the CloudCath System and laboratory reports and/or diagnosis
Agreement in detection of clinically relevant events based on CloudCath System, as compared to clinical laboratory results or diagnosis of a clinically relevant event.
Agreement in peritonitis detection between the CloudCath System and clinical criteria.
+1 more

ACT Trial Design

1Treatment groups
Experimental Treatment
Group I: CloudCath detectionExperimental Treatment1 Intervention
Active monitoring of dialysate effluent by the CloudCath System.

Find a Location

Who is running the clinical trial?

CloudCathLead Sponsor
3 Previous Clinical Trials
1,243 Total Patients Enrolled
Glenn Chertow, MDStudy DirectorStanford University
5 Previous Clinical Trials
3,169 Total Patients Enrolled

Media Library

CloudCath System (Diagnostic Device) Clinical Trial Eligibility Overview. Trial Name: NCT05285436 — N/A
Peritoneal Dialysis Peritonitis Research Study Groups: CloudCath detection
Peritoneal Dialysis Peritonitis Clinical Trial 2023: CloudCath System Highlights & Side Effects. Trial Name: NCT05285436 — N/A
CloudCath System (Diagnostic Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05285436 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could individuals still qualify for this clinical experimentation?

"The clinical trial data hosted on clinicaltrials.gov reveals that this particular medical investigation is no longer recruiting patients, as it was first posted in March 16th of 2022 and last updated in July 20th 2022. Nonetheless, 200 other trials are at the moment actively welcoming volunteers for enrollment."

Answered by AI
~78 spots leftby Dec 2024